Organization · Venture Capital
Tin Alley Ventures
Tin Alley Ventures is a venture capital fund based in Melbourne, Australia, focusing on deep tech startups affiliated with the University of Melbourne. It aims to transform research intellectual property into commercially viable companies.
Overview
What Tin Alley Ventures does
What Tin Alley Ventures is
Tin Alley Ventures is a venture capital fund based in Melbourne, Australia, focusing on deep tech startups affiliated with the University of Melbourne. It aims to transform research intellectual property into commercially viable companies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2022
- Approximate age
- About 4 years
- Structured capabilities
- Funder
- Last reviewed
- March 18, 2026
Official channels
Find Tin Alley Ventures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Tin Alley Ventures as a funder
Investment thesis
Tin Alley Ventures focuses on transforming research intellectual property from the University of Melbourne into commercially viable deep tech startups, particularly in life sciences and physical sciences.
Focus narrative
The fund invests in startups from seed to pre-IPO stages, with a primary focus on life sciences and physical sciences. Tin Alley Ventures seeks to support globally competitive companies founded by researchers, students, and alumni of the University of Melbourne and its affiliated institutes. Investments typically range from A$500,000 to A$5 million.
Value beyond capital
Tin Alley Ventures adds value to its portfolio companies by leveraging its connections within the University of Melbourne ecosystem, providing access to research resources, expertise, and a network of potential collaborators and customers.
Terms and economics
- Typical check
- $500,000–$5,000,000
Focus and fit
- Stages
- Seed · Pre-IPO
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 9
- Recorded notable exits
- Apromore
Portfolio context
Notable portfolio companies include: Synchron: A clinical-stage neurotechnology company developing an endovascular brain-computer interface (BCI). Cell Bauhaus: Focused on understanding, predicting, and altering cellular behavior to harness the power of living organisms. Porous Lane: Developed environmentally friendly pathways that capture and reuse water. Apromore: A collaborative process mining platform acquired by Salesforce in 2025. Neurala Biosciences: Developing therapeutics inspired by botanical principles. exteRNA: Working on first-in-class inhibitors for cancer treatment. Proxima Bio: Developing degraders targeting incurable diseases. Gallant Bio: A pre-clinical stage company targeting obesity and type 2 diabetes. i14 Intelligent Silicon: Building a novel LLM architecture for improved AI processing efficiency.
Common questions
What to know about Tin Alley Ventures
Upseed classifies Tin Alley Ventures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 18, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.